Holen Sie sich die Stockscreener-App
2.70
1.46%
-0.04
Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
6.84%
2.505
|
2.689 | 2.786 | 3.089 | 3.15 |
| Interest Income/Expense |
94.00%
0.006
|
0.10 | 0.011 | 0.111 | 0.072 |
| Operating Income/Loss |
6.84%
-2.505
|
-2.689 | -2.786 | -3.089 | -3.15 |
| Nonoperating Income/Loss |
129.00%
0.078
|
-0.269 | -1.38 | -0.031 | -0.071 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
17.95%
-2.427
|
-2.958 | -4.166 | -3.12 | -3.221 |
| Diluted Average Shares |
266.98%
2.712
|
0.739 | - | 0.787 | 0.574 |
| Diluted Earnings Per Share |
77.75%
-0.89
|
-4.00 | - | -3.97 | -5.61 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):